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Abstract 1 
Early-Onset Ataxia (EOA) and Developmental Coordination Disorder (DCD) are two 2 
conditions that affect coordination in children. Phenotypic identification of impaired 3 
coordination plays an important role in their diagnosis. Gait is one of the tests included in 4 
rating scales that can be used to assess motor coordination. 5 
A practical problem is that the resemblance between EOA and DCD symptoms can hamper 6 
their diagnosis. In this study we employed inertial sensors and a supervised classifier to 7 
obtain an automatic classification of the condition of participants. Data from shank and waist 8 
mounted inertial measurement units were used to extract features during gait in children 9 
diagnosed with EOA or DCD and age-matched controls. We defined a set of features from 10 
the recorded signals and we obtained the optimal features for classification using a backward 11 
sequential approach. We correctly classified 80.0%, 85.7%, and 70.0% of the control, DCD 12 
and EOA children, respectively. Overall, the automatic classifier correctly classified 78.4% 13 
of the participants, which is slightly better than the phenotypic assessment of gait by two 14 
pediatric neurologists (73.0%). These results demonstrate that automatic classification 15 
employing signals from inertial sensors obtained during gait maybe used as a support tool in 16 
the differential diagnosis of EOA and DCD. Furthermore, future extension of the classifier’s 17 
test domains may help to further improve the diagnostic accuracy of pediatric coordination 18 
impairment. In this sense, this study may provide a first step towards incorporating a 19 
clinically objective and viable biomarker for identification of EOA and DCD. 20 
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Introduction 24 
Coordination is characterized by smooth and efficient goal directed movements that involve 25 
different parts of the body. Correct anticipation and knowledge of where the body is located 26 
in space (proprioception) are essential for the execution of motor tasks requiring 27 
coordination. The cerebellum plays a pivotal role in the organization of planned coordination. 28 
It integrates input from different motor and multisensory feedback signals of different body 29 
regions. Gait requires a complex interaction of different muscles to maintain balance while 30 
moving forward, and even though children start to walk around their first year of age, it 31 
continues developing at least until the age of eleven [1]. Gait therefore can be affected by 32 
impaired coordination. In children, coordination can be affected due to different causes, such 33 
as ataxia, developmental coordination disorder (DCD) and physiological immaturity of the 34 
cerebellar circuitry in young children. Early-Onset Ataxia (EOA) is characterized by 35 
chronically impaired coordination of voluntary, goal directed movements starting before the 36 
25th year of life[2–5]. The underlying etiology is either associated with dysfunctional 37 
cerebellar networks or with abnormal spinal afferent input. Many of the heterogeneous 38 
underlying genetic causes of EOA will show progression over time, resulting in wheelchair 39 
dependency and even shorter life expectancy [6]. DCD is characterized by abnormal 40 
coordination impairment, after the exclusion of medical (behavioral or neurological) 41 
conditions as the underlying cause. DCD may involve impaired acquisition of motor skills, 42 
sensorimotor integration, postural control, strategic planning, visual-spatial processing and 43 
executive functioning[7–9]. Although the future perspective of DCD is much more optimistic 44 
compared to EOA, patients diagnosed with DCD may experience motor difficulties even into 45 
adulthood [7]. With treatment, functional outcome in these children can be improved[7]. 46 
Finally, in young healthy children (CTRL), immaturity of the cerebellar circuitry is 47 
characterized by normal, physiologically immature coordination, with features that can mimic 48 
“ataxia” [5,10]. As implicated by the descriptions, these three clinical entities for 49 
coordination impairment are characterized by overlapping features, which potentially 50 
hampers unanimous phenotypic recognition. However, due to the different future 51 
perspectives and treatment options, early distinction between EOA, DCD and healthy 52 
controls is desirable. In addition, adequate distinction between EOA and DCD will hopefully 53 
improve the yield of innovative genetic strategies and enhance the quality of data entry in 54 
international EOA databases.  55 
In absence of reliable distinctive biomarkers, the Scale for Assessment and Rating of Ataxia 56 
(SARA), is often used as an additional, supportive biomarker to indicate ataxia severity [11]. 57 
Despite the high reliability of the scale, we have shown that pediatric SARA is confounded 58 
by other factors than ataxia, as well [5,10,12]. Nevertheless, we have shown that the relative 59 
SARA gait subscore can support the recognition of an indisputable EOA phenotype in mildly 60 
affected participants[13]. Presently available quantitative gait parameters [14] are still not 61 
ubiquitously implemented as a clinical tool. Based on the remarks reported above, we 62 
reasoned that clinically simple and reproducible quantitative gait analysis could be 63 
worthwhile for reliable EOA and DCD recognition.  64 
In the present paper, we evaluate a method for the automatic and objective assessment of 65 
pediatric gait as compared to a clinical diagnosis in a similar way to what was previously 66 
done for other pathological conditions [15,16]. Additionally, the accuracy of phenotypic 67 
assessments is estimated. Both methods classify patients into three groups (EOA, DCD and 68 
CTRL). To be effective, the automatic assessment is expected to guarantee both a limited 69 
increase of the complexity of the evaluation and a minimal impact on the gait patterns under 70 
evaluation. As a result, we chose to apply a supervised classification algorithm to gait 71 
kinematics patterns recorded with few, light weight, wearable inertial measurement units 72 
(IMUs). Some of the features employed were obtained by modeling gait sequences with 73 
Hidden Markov Models (HMMs), which were shown to be effective in analyzing gait 74 
sequence data acquired with IMUs [17–22].  75 
 76 
Materials and methods 77 
Participants 78 
The study was performed in accordance with the research and integrity codes of the UMCG. 79 
Since gait assessment is routinely performed as part of scoring of the SARA during clinical 80 
assessment, the Medical Ethical Committee of the UMCG provided a waiver for ethical 81 
approval. After informed consent by the parents and informed assent by the participants 82 
(when older than 12 years of age), we included ten EOA [m 13.3 (sd 3.8) years], seven DCD 83 
[m 9.6 (sd 2.2) years] and twenty age-matched CTRL [m 12.1 (sd 3.3) years] children. There 84 
were no significant age differences between groups (ANOVA, p=0.07). 85 
The inclusion criterion for EOA was clinically assessed ataxia before the 25th year of life, 86 
either confirmed by a prior diagnosis and/or confirmed by two specialists from the movement 87 
disorders team (with access to the clinical radiologic evaluations, metabolic tests and genetic 88 
data). Identified EOA diagnoses involved: Niemann Pick Type C (n=1), MHBD-deficiency 89 
(n=1), Friedreich’s Ataxia (n=2), CACNA1A (n=2) and unknown (n=4). The inclusion 90 
criterion for DCD was the assessment of impaired coordination as clinically established by an 91 
independent rehabilitation clinician, according to DSM-IV-TR[23], after exclusion of a 92 
movement disorder by a neurologist. The inclusion criteria for healthy young children were 93 
the ability to follow mainstream education and absence of any neurological or orthopedic 94 
disorder as well as other physical conditions or prescribed medication that could theoretically 95 
interfere with the execution of SARA tasks.  96 
The SARA scale represents an ataxia rating scale in the domains of gait, upper limbs 97 
coordination, and speech, with scores varying from zero (no ataxia) to the maximum severity 98 
of 40[11]. The SARA gait subscore varies from zero (no difficulties in walking) to eight 99 
(unable to walk). We compared SARA score and SARA gait subscore between groups using 100 
an ANOVA test in case of normally distributed data and a Kruskal-Wallis test for non-101 
normally distributed data.  102 
During their visit to the UMCG outpatient clinic, we videotaped the SARA performances of 103 
all participants. The SARA gait evaluation consists of the assessment of 1) walking at a safe 104 
distance parallel to a wall and 2) walking in tandem without support [11]. In this study we 105 
focused on 1). According to SARA guidelines [11], participants were asked to walk in a 106 
straight line at their own speed in a corridor of approximately 15 meters, turn 180o and return 107 
to the starting position. We strived to obtain a similar number of strides and trials from all 108 
participants. However, due to their condition, the number of recorded strides varied across 109 
participants. In particular, the gait segmentation algorithm identified 54.4±17.3 strides (mean 110 
±standard deviation) for control subjects, 53.6±12.8 strides for DCD patients and 40.9±16.9 111 
strides for EOA patients. These performances were recorded by six IMUs (Shimmer3, 112 
Shimmer, Dublin, Ireland) including three accelerometers and three gyroscopes that were 113 
attached to the body with elastic straps. Data were recorded at a sampling rate of 256 Hz 114 
while participants performed the tasks described in the SARA. Before each recording IMUs 115 
were calibrated using software from the manufacturer (Shimmer 9DoF Calibration v2.5). One 116 
IMU was placed on the sternum, another one on the low back close to the L3 vertebra, two 117 
were placed bilaterally halfway each upper leg over the quadriceps and two on the lateral side 118 
of the shanks, just above the malleolus. This set-up was chosen to be able to carry out various 119 
analyses including joint kinematics analysis during SARA motor tasks. However, given the 120 
goal of this study, only data from a subset of IMUs was used.  121 
 122 
Clinical diagnosis  123 
Three experienced pediatric assessors (two pediatric neurologists and a movement disorders 124 
investigator specialized in ataxia) performed quantitative SARA assessments. Previous 125 
publications have shown that the SARA score is reliable when assessed by this group [5,12].  126 
 127 
Phenotypic assessment  128 
After a time interval of six months, two pediatric neurologists independently assessed the 129 
phenotypic characteristics of the videotaped SARA gait performances and assigned the 130 
children to the EOA, DCD and CTRL gait-subgroups.  Prior to assessment, the pediatric 131 
neurologists did not have access to the clinical or previous scoring data. 132 
 133 
Automatic classification 134 
The automatic classification of patients into the three groups (CTRL, DCD and EOA) was 135 
carried out similarly to a previous work [17], in which data from three groups (healthy 136 
elderly, hemiparetic patients and patients with Huntington’s disease) were classified based on 137 
data obtained from wearable IMUs. Seven IMU-derived signals were selected among the 138 
IMU-derived signals recorded during each gait trial. Six of them were extracted from an IMU 139 
positioned on the shank: the medio-lateral (ML) angular velocity and its approximated 140 
derivative, the antero-posterior (AP) acceleration and its approximated derivative, the 141 
approximated derivatives of the ML and vertical (VT) accelerations[14], [20]. A single signal 142 
was extracted from the IMU attached to the lower back (the ML acceleration) [17]. The 143 
above mentioned signals were selected since, in a previous work, they were found to be 144 
suitable for recognizing gait alterations, [17].  A schematic of the method is presented in 145 




Figure 1: schematic summarizing the proposed methodology for automatic classification. Variables containing 150 
information suitable for classification purposes (features) were extracted from the selected IMU signals. An 151 
automatic procedure to reduce the complexity of the classification problem was included (feature selection) and 152 
then an automatic classifier was validated. The results of each tested walking trial were then summarized to 153 
provide a single output for each subject (with the majority voting method). The results were then compared to 154 
the phenotypic assessment. 155 
 156 
The signals derived from the shank-mounted IMUs recorded during the walking trials were 157 
processed to extract classification features. From each of the selected IMU signals six 158 
features in the time domain and six in the frequency domain were extracted (12x7 = 84 159 
features). Six additional features were obtained by modeling gait sequences using Hidden 160 
Markov Models (HMMs) [17](Table 1). HMMs are a pattern recognition method that 161 
provides a statistical framework for modeling signals [25]: the resulting signal models can be 162 
specific to particular conditions and can then be used to classify new data by evaluating 163 
which specific model better explains new data (model likelihood evaluation). HMMs were 164 
trained in a supervised way by pairing stance and swing phases of gait to model states[22]. 165 
Reference gait events were extracted from the IMU signals using a previously validated 166 
method for gait segmentation [26]. To obtain HMM-based features, a model was trained for 167 
each of the three groups at each validation step. In particular, the data likelihood under each 168 
model was evaluated and provided six additional features to be used for classifying data 169 
during the testing phase: three features were obtained by the evaluation of model likelihoods 170 
on 2-second windows of data and three features were obtained by comparing the likelihood 171 
evaluated across the full length of the walking trials[17].  172 
 173 
Features that did not improve the classification accuracy were sequentially discarded, one at a 174 
time, by means of an automatic method, the sequential backward feature selection [27]. The 175 
cross-validation accuracy was used as the criterion for each selection step. 176 
After the automatic selection of a subset of the original 90 features, a classification algorithm 177 
was applied. A support vector machine (SVM) classifier with a radial basis function kernel 178 
was used. Classifier parameters were retained from a previous work: the upper complexity 179 
bound and the kernel variability were fixed to C = 100 and γ= 0.01, respectively [17]. The 180 
classifier was trained using a weighted cost function to limit the effect of class unbalance 181 
using the LibSVM implementation.[28] 182 
A leave-one-subject-out (LOSO) cross-validation was performed for both training phases 183 
(HMMs and SVM). At each validation step, data from one participant were excluded from 184 
the training set and the solution obtained was tested on data from the excluded participant. 185 
This was then repeated to test all participants in the dataset and results were aggregated by 186 
summing the confusion matrices obtained at each step. 187 
The results obtained from the SVM classifier referred to single walking trials. To classify a 188 
patient, a majority voting strategy [27] was applied for which the classification output of each 189 
side in each walking trial generated a vote. The class collecting most votes was then selected 190 
as the winner of the poll. A heuristic rule to deal with ties was introduced. 191 
 192 
Classification accuracy  193 
The accuracy of the phenotypic assessment and of the automatic classification are presented 194 
as confusion matrices using the clinical diagnosis as reference. The accuracy of the automatic 195 
classification was determined for single gait trials and after the majority voting. To facilitate 196 
a comparison between phenotypic assessment and the automatic classification the 197 
assessments of both evaluators were aggregated in one confusion matrix. 198 
 199 
Results  200 
Participant characteristics 201 
According to Shapiro-Wilk tests, the total SARA score and the gait score were normally 202 
distributed in the EOA and DCD groups but not in the CTRL group. Both total SARA and 203 
SARA-gait scores differed significantly between groups (Kruskal-Wallis test,p<0.01). Post-204 
hoc Mann-Whitney U tests revealed that SARA total scores were significantly higher in EOA 205 
than in DCD (p<0.01) and that SARA total scores were significantly higher in DCD than in 206 
CTRL (p<0.01). SARA gait scores were significantly different between groups, as well 207 
(Kruskal-Wallis test,p<0.01). Post-hoc Mann-Whitney U tests showed that SARA gait scores 208 
were significantly higher in EOA than in DCD (p<0.01) and that SARA gait scores were 209 
significantly higher in DCD than in CTRL (p<0.05) (Table 2). 210 
 211 
Feature selection 212 
The feature set obtained by applying the sequential backward feature selection is summarized 213 
in Table 1. Retained features are indicated with check marks: four out of six HMM-based 214 
features and 37 out of 84 features in the time and frequency domain were retained.  215 
 216 
Phenotypic assessment and automatic classification results  217 
The confusion matrix for the phenotypic assessment performed by the two specialists is 218 
reported in Table 3, part 1. Every assessment is reported as an entry for the confusion matrix. 219 
The SVM classifier output is summarized in confusion matrices reported in Table 3 (parts 2 220 
and 3). The first classification output describes the walking trials classification and shows 221 
that 63.8% of walking trials were assigned to the correct group. The majority voting resulted 222 
in correct classification for 78.4% of participants. In particular, no DCD or EOA participants 223 
were incorrectly classified as CTRL. However, four CTRL participants were mistakenly 224 
classified as DCD or EOA and a few misclassifications occurred between EOA and DCD. 225 
The relation between the SARA gait subscore and the classifier output is shown in figure 2. 226 
 227 
Figure 2: SARA gait scores for controls (green dots), DCD (blue dots) and EOA (red dots) participants in 228 




In this study, we presented an automatic assessment of gait in EOA, DCD and healthy 233 
“immature” control children that could support the currently challenging phenotypic 234 
recognition of such conditions.  We implemented a method for the automatic classification of 235 
wearable inertial sensors data from gait trials according to three categories of coordination 236 
impairment. To assess the accuracy of the method, we compared the quantitative gait 237 
outcomes with: (a) the clinical diagnosis based on genetic, radiologic, neurologic and/or 238 
metabolic data; and (b) the observed phenotype (as determined by clinical specialists of 239 
movement disorders).To assess the accuracy of the method, we determined the percentage of 240 
correct classification and of misclassification using the clinical diagnosis as reference. We 241 
then compared the accuracy of the automatic classification method with that of the 242 
phenotypic assessment as determined by clinical specialists in movement disorders.  We 243 
reasoned that if quantitative gait features are able to distinguish between EOA, DCD and 244 
CTRL groups, this technique could provide an objective tool for the identification of EOA 245 
and DCD. Overall, the classifier obtained an accuracy of 78.4%, which is 5.4% higher than 246 
the mean accuracy of the phenotypic assessment. From these data, we conclude that the 247 
quantitative gait features, as provided by the automatic classifier, can provide a supportive 248 
tool for unanimous and reproducible diagnostic assessment.  249 
For the purpose of this discussion we looked into some individual misclassification cases. 250 
The automatic classifier placed one DCD participant in the EOA group. This is most 251 
probably due to the accidental misplacement of the shank mounted IMUs, occurred in the 252 
participant data acquisition session and recognized by analyzing the video-recordings of his 253 
walking trials. Interestingly, this participant was placed in the CTRL group by both 254 
evaluators. The automatic classifier misclassified three EOA and two CTRL participants, 255 
placing them in the DCD group. In two of these cases, one of the two evaluators agreed with 256 
the automatic classifier. There were two cases of misclassified CTRL participants in the EOA 257 
group. These participants were placed in the EOA and DCD groups and in the DCD and 258 
CTRL groups respectively by the evaluators. They also obtained impaired/sub-optimal SARA 259 
gait subscores, suggesting that phenotypical assessment and automatic classification 260 
identified a sub-optimal/impaired coordination.  261 
Comparing the automatic classifier assessment with the phenotypic assessment revealed a 262 
higher diagnostic accuracy by the former in DCD subjects (50% higher) and a higher 263 
diagnostic accuracy by the latter in EOA patients (20% higher). For controls, both methods 264 
revealed similar accuracies, with a slightly higher accuracy of the automatic classifier (2.5 % 265 
higher).  266 
To explain the outcomes of this study, it is crucial to elaborate on the characteristics of the 267 
three methods of classifications utilized: the clinical diagnosis, the phenotypic assessment, 268 
the automatic method consideration. The clinical diagnosis is the result of the evaluation of 269 
all potentially useful parameters. This may implicate that indicators other than gait 270 
parameters (such as genetic, radiologic, laboratory) could have been decisive for the clinical 271 
diagnosis. From this perspective, a different classification between the clinical diagnosis and 272 
the automatic gait classifier does not necessarily imply a poor performance of the classifier. 273 
For instance, a child with a genetic diagnosis and discrete changes in tandem gait does not 274 
necessarily reveal abnormalities in the walking pattern that can be picked up by the classifier. 275 
Similarly, the phenotypic assessment which is based on videotaped SARA gait performances 276 
could be heavily affected by the observation of tandem gait, standing and by the perception of 277 
the age of the child, expressions that were not included in the recordings processed by the 278 
automatic classification, which is applied only to data recorded during straight walking. 279 
Considering that the automatic classifier was applied exclusively to straight gait recordings, a 280 
78% classification accuracy is very promising. Once the automatic classifier application will 281 
be extended to other SARA gait and kinetic parameters, it is expected that the accuracy of 282 
this method will increase.  283 
Interestingly, the phenotypic assessment revealed a higher sensitivity for EOA patients, 284 
whereas the automatic classifier revealed a higher sensitivity for DCD and control subjects. 285 
As EOA represents a neurologic diagnosis, and as DCD represents a practical rehabilitation 286 
diagnosis (after exclusion of neurologic abnormalities), it appears hardly surprising that 287 
pediatric neurologists are better skilled to identify EOA than DCD. As specific standards for 288 
DCD recognition are still missing, it appears tempting to speculate that future classifier-based 289 
assessments of additional DCD domains may assist further delineation of this broad 290 
diagnostic group. Within the limitation of the present study, we would thus suggest that 291 
future extension of the classifier’s test domains and also inclusion of a larger number of 292 
patients may help to improve the diagnostic accuracy of pediatric coordination impairment. 293 
Hopefully, this study provides a first step towards incorporating a clinically objective and 294 
viable biomarker for uniform identification of EOA and DCD.  295 
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Table 1.Feature set for classification, adapted from[17]. Check marks indicate the feature set after the 
automatic feature selection strategy. Data channels obtained by approximated derivatives are 
indicated with a “d”. 
Category Feature Channel  
(a check mark indicates that the feature has been 
selected by the automatic selection strategy) 


















Mean value    ✓ ✓ ✓ ✓ ✓ 
Standard deviation   ✓  ✓  ✓ 
Variance   ✓ ✓    
Maximum  ✓  ✓ ✓   
Minimum ✓       




Power at first dominant freq. (P1) ✓   ✓    
Power at second dominant freq.  ✓   ✓ ✓  
First dominant frequency    ✓ ✓ ✓ ✓ 
Second dominant frequency   ✓ ✓ ✓ ✓ ✓ 
Total power (PT)  ✓    ✓  







all the seven 
data 
channels) 
Log-likelihood, CTRL model 
(limited to a 2-s window)  
✓ 
Log-likelihood, DCD model 
(limited to a 2-s window) 
 
Log-likelihood, EOA model 
(limited to a 2-s window) 
 
Difference between log-
likelihoods for CTRL and DCD 
models (for all available data) 
✓ 
Difference between log-
likelihoods for CTRL and 
EOAmodels(for all available data) 
✓ 
Difference between log-
likelihoods for DCD and 





Table 2. Participant characteristics. 


































Table 3.Confusion matrices for the group classification.To facilitate a comparison between phenotypic 
assessment and automatic classification the assessments of both evaluators were aggregated. Results 
obtained by phenotypic assessment are in part 1. Results obtained using the automatic classifier for 
single walking trials (part 2) and after majority voting (part 3). 
  
 
Phenotype classification output  
CTRL DCD EOA 
1. phenotypic assessment output 
Clinical 
Diagnosis 
CTRL 31         (77.5%) 8           (20.0%) 1          (2.5%) 
DCD 4           (28.6%) 5           (35.7%) 5          (35.7%) 
EOA 0 (0.0%) 2           (10.0%) 18        (90.0%) 




Automatic classification output  
CTRL DCD EOA 
2. automatic classification output for single walking trials 
Clinical 
Diagnosis 
CTRL 107  (61.5%) 39 (22.4%) 28 (16.1%) 
DCD 5  (8.3%) 36 (60.0%) 19 (31.7%) 
EOA 1  (1.4%) 18 (25.7%) 51 (72.9%) 
 Overall accuracy 63.8% of walking episodes 
 
3. automatic classification output after majority voting 
Clinical 
Diagnosis 
CTRL 16 (80.0%) 2 (10.0%) 2 (10.0%) 
DCD 0  (0%) 6 (85.7%) 1 (14.3%) 
EOA 0 (0%) 3 (30.0%) 7 (70%) 
 Overall accuracy 78.4% of participants  
  
 
 
